CVE-2020-27260
Official description Straight from the sourceThe vendor's or NVD's own wording, published unedited. Authoritative, but often terse — it says what broke, rarely what to do.
NVD · uneditedInnokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 HL7 v2.x injection vulnerabilities exist in the affected products that allow physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific HL7 v2.x messages via multiple expected parameters.
Technical summary Written by usOur analysis, written from the advisory, the CVSS vector and the affected-version data. It adds context the advisory leaves out, and never invents facts that are not in the source.
dbcve analysis · high confidenceInnokas Vital Signs Monitor VC150 versions prior to 1.7.15 contain HL7 v2.x injection vulnerabilities allowing a physically proximate attacker with a connected barcode reader to inject arbitrary HL7 v2.x segments into specific HL7 v2.x messages through multiple expected input parameters.
Verify against the referenced sources before acting — the references below are authoritative for this CVE, this summary is not.
Affected products & versions What the vendor confirmedThe version ranges the vendor confirmed as vulnerable. If your version sits inside a range here, treat yourself as exposed until you have upgraded.
NVD · CPE data< 1.7.15CVSS breakdown How the score is builtThe industry scoring standard. It rates how the flaw is reached, what it takes to exploit, and what an attacker gains — the score is derived from those, not the other way round.
From the vector- Attack vector
- Physical
- Complexity
- Low
- Privileges
- None
- User interaction
- None
- Scope
- Changed
- Confidentiality
- None
- Integrity
- High
- Availability
- None
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:C/C:N/I:H/A:N
Am I affected? How to checkSteps we derive from the advisory and the affected-version data, so you can decide whether this CVE reaches your setup. They are a guide, not a scan — your own configuration is the authority.
dbcve checksWork through these to decide whether this CVE applies to you.
-
Confirm the device modelIdentify if the target device is an Innokasmedical Vital Signs Monitor VC150. This is typically visible on the device physical label, startup screen, or management interface.Affected if The device is not an Innokas VC150 model - this CVE only applies to that specific product.
-
Determine the installed firmware versionAccess the device system information or firmware version menu, typically found in the device settings, service mode, or system diagnostics screen. Compare the displayed firmware version to the affected range of < 1.7.15.Affected if The firmware version is lower than 1.7.15 (for example, 1.7.10, 1.6.8, etc.).
-
Check if HL7 v2.x interface is enabledExamine the device configuration or integration settings to verify whether HL7 v2.x message exchange is configured and active on the device.Affected if HL7 v2.x interface is enabled and configured for data exchange.
-
Verify barcode reader connectivityInspect the device physical ports and configuration settings to determine if a barcode reader is connected or configured as an input method for patient/data entry.Affected if A barcode reader is connected to the device and enabled as an input interface.
-
Assess physical access exposureEvaluate whether the device is located in an area where an unauthorized individual could physically access it with a barcode reader, considering the attack requires physical proximity.Affected if The device is in an area with uncontrolled physical access where an attacker could connect a barcode reader.
A user is affected if they have an Innokas VC150 device with firmware version below 1.7.15 that has both HL7 v2.x enabled and a barcode reader connected, in a physically accessible location.
Generated from the published advisory. Verify against your own configuration.
Remediation Closing itWhat it takes to close this. Where a vendor fix exists we point at it; where none exists we say so plainly, and can build one. Effort estimates are scoped from the advisory, not from your codebase.
From vendor data1.7.15
Upgrade Innokas VC150 Vital Signs Monitor to version 1.7.15 or later to remediate the HL7 v2.x injection vulnerability.
- Consultation4.0 h
- Implementation8.0 h
- Testing4.0 h
- Review / QA2.0 h
An estimate, not a bill — we confirm scope with you before any work starts. Need it this week? Rush from $5,120.
Scan for this in your stack
Free · runs locallyCheck whether your project pulls in CVE-2020-27260 — or any other known-vulnerable package — straight from your lock files. Free and open source; it runs locally and uploads nothing.
References Go to the primary sourcePrimary sources — vendor advisories, patches and trackers. Where our summary and a reference disagree, the reference wins.
Primary sourcesPractitioner notes
ContributedPeer-ranked notes from engineers who’ve handled CVE-2020-27260 in production — separate from our analysis above.
The advisory tells you what broke. It rarely tells you what actually worked. If you’ve dealt with this one, that detail is what the next engineer is searching for.
- The version that genuinely resolved it — not the one the vendor claimed
- A config change or rule that shut the vector down
- A gotcha in the upgrade path that cost you an afternoon
No notes yet
Be the first to add a field note for this CVE — a mitigation you’ve verified, a version caveat, or a link to a working fix. Sign in above to contribute.
A place for practitioners to share what actually worked: a mitigation you’ve tested, a configuration change, a version- or environment-specific caveat, or a link to a verified patch. The most useful notes rise to the top as peers upvote them, so the signal stays high.
- Verified mitigations, workarounds, and config changes
- Version or environment caveats, and links to real fixes
- No weaponised exploit code, or anything meant to cause harm
- No spam, self-promotion, credentials, or personal data